Cargando…
DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288328/ http://dx.doi.org/10.1186/2051-1426-2-S3-O17 |
| _version_ | 1782351947856084992 |
|---|---|
| author | Humeau, Laurent Trimble, Cornelia Morrow, Matthew Shen, Xuefei Dallas, Michael Weiner, David Boyer, Jean Yan, Jian Kraynyak, Kimberly Sylvester, Albert Giffear, Mary Marcozzi-Pierce, Kathy Shah, Divya Broderick, Kate Khan, Amir Lee, Jessica Sardesai, Niranjan Bargarazzi, Mark |
| author_facet | Humeau, Laurent Trimble, Cornelia Morrow, Matthew Shen, Xuefei Dallas, Michael Weiner, David Boyer, Jean Yan, Jian Kraynyak, Kimberly Sylvester, Albert Giffear, Mary Marcozzi-Pierce, Kathy Shah, Divya Broderick, Kate Khan, Amir Lee, Jessica Sardesai, Niranjan Bargarazzi, Mark |
| author_sort | Humeau, Laurent |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288328 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42883282015-01-15 DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial Humeau, Laurent Trimble, Cornelia Morrow, Matthew Shen, Xuefei Dallas, Michael Weiner, David Boyer, Jean Yan, Jian Kraynyak, Kimberly Sylvester, Albert Giffear, Mary Marcozzi-Pierce, Kathy Shah, Divya Broderick, Kate Khan, Amir Lee, Jessica Sardesai, Niranjan Bargarazzi, Mark J Immunother Cancer Oral Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288328/ http://dx.doi.org/10.1186/2051-1426-2-S3-O17 Text en Copyright © 2014 Humeau et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Humeau, Laurent Trimble, Cornelia Morrow, Matthew Shen, Xuefei Dallas, Michael Weiner, David Boyer, Jean Yan, Jian Kraynyak, Kimberly Sylvester, Albert Giffear, Mary Marcozzi-Pierce, Kathy Shah, Divya Broderick, Kate Khan, Amir Lee, Jessica Sardesai, Niranjan Bargarazzi, Mark DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial |
| title | DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial |
| title_full | DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial |
| title_fullStr | DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial |
| title_full_unstemmed | DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial |
| title_short | DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial |
| title_sort | dna vaccine vgx-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears hpv infection with robust t cell responses: results of a randomized, double-blind, placebo-controlled phase ii trial |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288328/ http://dx.doi.org/10.1186/2051-1426-2-S3-O17 |
| work_keys_str_mv | AT humeaulaurent dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT trimblecornelia dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT morrowmatthew dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT shenxuefei dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT dallasmichael dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT weinerdavid dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT boyerjean dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT yanjian dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT kraynyakkimberly dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT sylvesteralbert dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT giffearmary dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT marcozzipiercekathy dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT shahdivya dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT broderickkate dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT khanamir dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT leejessica dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT sardesainiranjan dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT bargarazzimark dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial AT dnavaccinevgx3100withelectroporationinducesregressionofcervicalintraepithelialneoplasia23andclearshpvinfectionwithrobusttcellresponsesresultsofarandomizeddoubleblindplacebocontrolledphaseiitrial |